Azaperone
Specifications
1649-18-9CAS Number
216-715-8EC Number
1-(4-fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-1-oneIUPAC Name
C19H22FN3OChemical Formula
327.4 g/molMolecular Weight
Azaperone; 1649-18-9; Fluoperidol; Stresnil; Suicalm; Azaperon; Azaperona; R-1929; Azaperonum; 1-Butanone, 1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-; NSC 170976; DTXSID2045361; R 1929; 1-(3-(4-Fluorobenzoyl)propyl)-4-(2-pyridyl)piperazine; 1-(4-Fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butanone; 4'-Fluoro-4-(4-(2-pyridyl)-1-piperazinyl)butyrophenone; Azaperone for veterinary use; NSC-170976; 19BV78AK7W; 1-Butanone, 1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-; 4'-Fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone; DTXCID0025361; CHEBI:88301; 1-(4-Fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-1-butanone; Stresnil Injection; RefChem:57775; R1929; SID11112496; 216-715-8; Azeperone; Eucalmyl; Sedaperone vet; C19H22FN3O; 1-(4-fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-1-one; 1-(4-fluorophenyl)-4-(4-(pyridin-2-yl)piperazin-1-yl)butan-1-one; MFCD00866692; 1-(4-fluorophenyl)-4-[4-(pyridin-2-yl)piperazin-1-yl]butan-1-one; MLS003106751; CHEMBL340211; NSC170976; NCGC00016590-01; Butyrophenone, 4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]-; CAS-1649-18-9; 1-(4-fluorophenyl)-4-[4-(2-pyridyl)piperazin-1-yl]butan-1-one; Azaperonum [INN-Latin]; BUTYROPHENONE, 4'-FLUORO-4-(4-(2-PYRIDYL)-1-PIPERAZINYL)-; Azaperona [INN-Spanish]; Azaperone (1.0 mg/mL in Methanol); SMR001233462; CCRIS 1586; SR-05000001712; EINECS 216-715-8; BRN 0565491; UNII-19BV78AK7W; Stresnil;; Azaperone CRS; Azaperone [USAN:USP:INN:BAN]; Stresnil (TN); Azaperone VETRANAL; Azaperone (Standard); Azaperone (USP/INN); AZAPERONE [INN]; AZAPERONE [MI]; AZAPERONE [USAN]; Prestwick0_001117; Prestwick1_001117; Prestwick2_001117; Prestwick3_001117; Spectrum2_001250; Spectrum3_001966; AZAPERONE [MART.]; AZAPERONE [USP-RS]; BSPBio_001254; BSPBio_003566; 5-23-03-00041 (Beilstein Handbook Reference); MLS002154163; SCHEMBL121134; SPECTRUM1505332; SPBio_001160; SPBio_003117; AZAPERONE [GREEN BOOK]; BPBio1_001379; orb1300802; AZAPERONE [USP IMPURITY]; SCHEMBL29437229; HY-B1470R; KBio3_002914; AZAPERONE [USP MONOGRAPH]; MSK7108; Lamotrigine 5-N-?-D-Glucuronide; Azaperone (1 mg/mL in Methanol); HMS1571O16; HMS1922D20; HMS2090K03; HMS2093D03; HMS2098O16; HMS2230C17; HMS3369I10; HMS3652D15; HMS3715O16; HMS3885F11; HMS5082B14; Pharmakon1600-01505332; EX-A9409; HY-B1470; YWB02172; Tox21_110512; BDBM50036733; CCG-39158; MSK7108-100A; NSC758969; PDSP1_000828; PDSP2_000815; s4219; STK802185; AKOS005622715; MSK7108-1000A; Tox21_110512_1; CS-5158; DB11376; FA18061; KS-5204; NSC-758969; Azaperone 100 microg/mL in Acetonitrile; NCGC00016590-02; NCGC00016590-03; NCGC00016590-04; NCGC00016590-06; NCGC00016590-08; NCGC00095171-01; NCGC00095171-02; NCGC00095171-03; SY067157; Azaperone 1000 microg/mL in Acetonitrile; SBI-0206748.P001; Azaperone for veterinary use [EP monograph]; WLN: T6N DNTJ D3VR DF& A- BT6NJ; A9801; AB00514057; NS00000088; SW196387-3; T6398; Azaperone Solution in Acetonitrile, 100ug/mL; Azaperone, VETRANAL(TM), analytical standard; Azaperone Solution in Acetonitrile, 1000ug/mL; C73189; D02620; AB00514057-06; AB00514057_07; F436632; L000791; Q4832244; SR-05000001712-1; SR-05000001712-3; BRD-K45861246-001-05-0; BRD-K45861246-001-08-4; BRD-K45861246-001-13-4; BRD-K45861246-001-14-2; BRD-K45861246-001-15-9; Azaperone, British Pharmacopoeia (BP) Reference Standard; {4'-Fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone}; 4'-Fluoro-4-[4-(2-pyridinyl)-1-piperazinyl]butyrophenone; Azaperone, European Pharmacopoeia (EP) Reference Standard; 1-(4-Fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-; Azaperone, United States Pharmacopeia (USP) Reference Standard; Butyrophenone, {4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]-}; 1-Butanone, {1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-}; 1-(4-Fluoro-phenyl)-4-(4-pyridin-2-yl-piperazin-1-yl)-butan-1-one(Azaperone)Synonyms
